scispace - formally typeset
M

Massimo Andreoni

Researcher at University of Rome Tor Vergata

Publications -  404
Citations -  8019

Massimo Andreoni is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 42, co-authored 350 publications receiving 6554 citations.

Papers
More filters
Journal ArticleDOI

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

John Gregson, +71 more
TL;DR: A global assessment of drug resistance after virological failure with first-line tenofovir-containing ART, defined as presence of K65R/N or K70E/G/Q mutations in the reverse transcriptase ( RT ) gene.
Journal ArticleDOI

Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.

TL;DR: The results indicate that PBMC that are polymerase chain reaction (PCR)-positive at day 0 generally loose the virus upon culture, and suggest that infected monocytes may carry the virus to tissues, transmit the infection, or differentiate in loco in spindle cells with endothelial macrophage markers.
Journal ArticleDOI

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor : Mutations, kinetics, and frequencies

TL;DR: There was a good relationship between genotypic analysis of saquinavir resistance and data from virus assays, confirming that Leu90-->Met and Gly48-->Val are the essential exchanges in the proteinase that determine loss of sensitivity to this inhibitor.
Journal ArticleDOI

Primary Human Herpesvirus 8 Infection in Immunocompetent Children

TL;DR: Primary infection with HHV-8 may be associated with a febrile maculopapular skin rash among immunocompetent children and the hypothesis that transmission through saliva is the main mode of transmission in the pediatric age group is supported.
Journal ArticleDOI

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.

TL;DR: Patients with SARS-CoV2 infection frequently present with subjective neurological symptoms (sNS), and laboratory findings correlated with the occurrence of hyposmia, dysgeusia, headache, daytime sleepiness, and depression.